1Gernot Stuhler,Peter Walden.Recruitment of helper T cells for induction of tumour rejection by cytolytic T lymphocytes[J]. Cancer Immunology Immunotherapy . 1994 (5)
2Kaido T,Bandu MT,Maury C et al.IFN-α 1 gene transfection completelyabolishes the tumorigenicity ofmurine B16 melanoma cells in allogeneicDBA/2 mice and decreasestheir tumorigenicity in syngeneicC57BL/6 mice. International Journal of Cancer . 1995
3Podack ER.Functional significance oftwo cytolytic pathways of cytotoxic Tlymphocytes. Journal of Leukocyte Biology . 1995
4Krummel MF,Allison JP.CD28 andCTLA-4 have opposing effects on theresponse of T cells to stimulation. The Journal of Experimental Medicine . 1995
5Boussiotis VA,Freeman GJ.GuibbenJG et al.Activated human B lymphocytesexpress three CTLA-4 counterreceptorsthat costimulate T-cell activation. Proceedings of the National Academy of Sciences of the United States of America . 1993
6Levine BL,Ueda Y.Craighead N etal.CD28 ligands CD80( B7-1) andCD86(B7-2) induce long-term autocrinegrowth of CD4+ T cells andinduce similar patterns of cytokine secretionin vitro. in vitro. International Immunology . 1995
7Cox AL,Skipper J,Cher Y et al.Identification of a peptidercognized by five melanoma-specific human cytotoxicT cell lines. Science . 1994
8Galea-Lauri J,Farzaneh F,Gaken J.Novel costimulators in the immunegene therapy of cancer. Cancer Genetics and Cytogenetics . 1996
10Gamero AM,Ussery D,ReintgenDS et al.Interleukin 15 induction oflymphokine activated killer cellfunction against autologens tumorcells in melanoma patient lymphocytesby a CD18-dependent perforinrelatedmechanism. Cancer Research . 1995
